JP Morgan Chase
SNCE

JP Morgan Chase’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

JP Morgan Chase’s Portfolio SNCE Stock Details SNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-295
Closed -$1.58K – 8045
2023
Q4 		$1.58K Buy
295
+284
+2,582% +$1.75K ﹤0.01% 6757
2023
Q3 		$85 Buy
11
+4
+57% +$24 ﹤0.01% 6930
2023
Q2 		$29 Sell
7
-2,409
-100% -$13.7K ﹤0.01% 6771
2023
Q1 		$14K Buy
2,416
+647
+37% +$4.92K ﹤0.01% 6059
2022
Q4 		$15K Buy
1,769
+91
+5% +$1.78K ﹤0.01% 5963
2022
Q3 		$54K Buy
1,678
+14
+0.8% +$519 ﹤0.01% 5524
2022
Q2 		$67K Buy
1,664
+935
+128% +$68.3K ﹤0.01% 5571
2022
Q1 		$78K Buy
729
+164
+29% +$25.7K ﹤0.01% 5616
2021
Q4 		$141K Buy
+565
New +$125K ﹤0.01% 5534

JP Morgan Chase's SNCE Position: Q1 2024 in Review

JP Morgan Chase sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q1 2024, closing a stake of 295 shares — an estimated $1.58K sold.

JP Morgan Chase first reported a position in SNCE in Q4 2021 and held it in 9 quarters. The position peaked at $141K in Q4 2021. 0 funds tracked by Wall St. Rank hold SNCE as of Q1 2024.

  • JP Morgan Chase reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • JP Morgan Chase sold 295 Science 37 Holdings, Inc. Common Stock shares in Q1 2024, an estimated $1.58K.
  • JP Morgan Chase first reported a position in Science 37 Holdings, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
  • JP Morgan Chase's Science 37 Holdings, Inc. Common Stock position peaked at $141K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q1 2024.

Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.